Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Raging Capital Took Activist Stake in Derma Sciences

Raging Capital filed on November 29th for its 13.5% activist stake in Derma Sciences, Inc. (DSCI). Raging Capital is one of DSCI’s insider. According to the filing, Raging Capital began to buy DSCI since late September and now has 1.46 million shares in DSCI. Raging Capital previously reported 513 thousand shares, or 8.3% passive stake in 2010. DSCI is now trading at $7.86, representing a 61% year to date return.

In the second quarter, two hedge funds reported their position in DSCI. Peter Kolchinsky’s RA Capital Management boosted its position by 16 times and had 772 thousand shares in the stock. Brian Bares’ Bares Capital Management had a much smaller position, with 15 thousand shares.

Peter Kolchinsky

Raging Capital Management is a small-to-mid-cap public equity focused hedge fund. The firm was founded by William C. Martin in 2006 in Princeton, NJ. Mr. Martin now serves as the Chairman and Chief Investment Officer in the firm.

Derma Sciences, Inc. is a medical device and pharmaceutical company with a primary focus on wound care. The company engages in manufacturing, marketing, and selling wound care, wound closure and specialty securement devices, and skin care products. The company primarily offers its products to health care agencies and institutions. The company also markets its products through retail channels. The company was founded in 1984 and is headquartered in Princeton, New Jersey.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!